Related references
Note: Only part of the references are listed.Development of hydrogel-forming microneedles for transdermal delivery of albendazole from liquid reservoir
Anugerah Yaumil Ramadhani Aziz et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2023)
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Hanan Bloomer et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction
Hanseul Park et al.
BIOMATERIALS (2022)
TGF-β1-based CRISPR/Cas9 Gene Therapy Attenuates Radiation-in- duced Lung Injury
Shuai Zhen et al.
CURRENT GENE THERAPY (2022)
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway
Shun-Qing Liang et al.
MOLECULAR THERAPY (2022)
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
Jeong Pil Han et al.
SCIENCE ADVANCES (2022)
Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver
Cory D. Sago et al.
NATURE BIOMEDICAL ENGINEERING (2022)
Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing
Jessica D. Gumerson et al.
GENE THERAPY (2022)
Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system
Jonathan O'Keeffe Ahern et al.
GENE THERAPY (2022)
Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
Yan Zou et al.
SCIENCE ADVANCES (2022)
Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
Misganaw Asmamaw Mengstie
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
Pardis Kazemian et al.
MOLECULAR PHARMACEUTICS (2022)
Nanodevices for the Efficient Codelivery of CRISPR-Cas9 Editing Machinery and an Entrapped Cargo: A Proposal for Dual Anti-Inflammatory Therapy
Alba Garcia-Fernandez et al.
PHARMACEUTICS (2022)
LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea
Seyedeh Zeinab Mirjalili Mohanna et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
Ahmed Salman et al.
PHARMACEUTICS (2022)
Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems
Faranak Hejabi et al.
FRONTIERS IN CHEMISTRY (2022)
Non-viral strategies for delivering genome editing enzymes
Jie Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Therapeutic advances in cardiac targeted drug delivery: from theory to practice
Cuican Li et al.
JOURNAL OF DRUG TARGETING (2021)
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing
Min Qiu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2021)
Delivery of CRISPR/Cas9 Plasmids by Cationic Gold Nanorods: Impact of the Aspect Ratio on Genome Editing and Treatment of Hepatic Fibrosis
Yuxuan Chen et al.
CHEMISTRY OF MATERIALS (2021)
CRISPR technologies for precise epigenome editing
Muneaki Nakamura et al.
NATURE CELL BIOLOGY (2021)
Controlling and enhancing CRISPR systems
Haridha Shivram et al.
NATURE CHEMICAL BIOLOGY (2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
Sikai Ling et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9
Lili Wang et al.
MOLECULAR THERAPY (2021)
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
Min Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver
M. Kim et al.
SCIENCE ADVANCES (2021)
In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers
Menglong Chen et al.
GENOME MEDICINE (2021)
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Li Duan et al.
FRONTIERS IN GENETICS (2021)
Sono-Controllable and ROS-Sensitive CRISPR-Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy
Yinying Pu et al.
ADVANCED MATERIALS (2021)
In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles
Yuyuan Wang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D. Gillmore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective
Billy Dunn et al.
JAMA INTERNAL MEDICINE (2021)
Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs
Joon Ho Park et al.
SCIENCE ADVANCES (2021)
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Matthew Behr et al.
ACTA PHARMACEUTICA SINICA B (2021)
Exosome-mediated delivery of gene vectors for gene therapy
Li Duan et al.
NANOSCALE (2021)
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
Song Zhang et al.
THERANOSTICS (2021)
Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina
Tien-Chun Yang et al.
ACTA BIOMATERIALIA (2020)
Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
Jee-Yeon Ryu et al.
BIOMATERIALS (2020)
Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
Yamin Li et al.
BIOMATERIALS (2020)
Treatment of a Mouse Model of ALS by In Vivo Base Editing
Colin K. W. Lim et al.
MOLECULAR THERAPY (2020)
Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing
Xiaohong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Strategies for the CRISPR-Based Therapeutics
Bin Li et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics
Fengqian Chen et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice
Koji M. Nishiguchi et al.
NATURE COMMUNICATIONS (2020)
A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency
Lili Wang et al.
SCIENCE ADVANCES (2020)
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
Yu Zhang et al.
SCIENCE ADVANCES (2020)
Protein and mRNA Delivery Enabled by Cholesteryl-Based Biodegradable Lipidoid Nanoparticles
Yamin Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
Multifunctional Nanocarriers for Lung Drug Delivery
Jorge F. Pontes et al.
NANOMATERIALS (2020)
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
Peter Gee et al.
NATURE COMMUNICATIONS (2020)
Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
Tuo Wei et al.
ACS NANO (2020)
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
Achraf Noureddine et al.
ACTA BIOMATERIALIA (2020)
Imidazole-Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
Xuewei Zhao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
Giulia Maule et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects
Shaohui Deng et al.
SCIENCE ADVANCES (2020)
Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection
Feihe Ma et al.
SCIENCE ADVANCES (2020)
Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
Muhammad Naeem et al.
CELLS (2020)
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Fathema Uddin et al.
FRONTIERS IN ONCOLOGY (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
The delivery challenge: fulfilling the promise of therapeutic genome editing
Joost van Haasteren et al.
NATURE BIOTECHNOLOGY (2020)
CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases
Sadiya Bi Shaikh et al.
CURRENT GENE THERAPY (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Hossein Rahimi et al.
NANO TODAY (2020)
Base editing: advances and therapeutic opportunities
Elizabeth M. Porto et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
CRISPR-Cas9-Mediated In Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice
Qingnan Wang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Xinfu Zhang et al.
SCIENCE ADVANCES (2020)
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Daniel Rosenblum et al.
SCIENCE ADVANCES (2020)
Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
Qi Liu et al.
BIOMATERIALS (2020)
Lipid and polymer mediated CRISPR/Cas9 gene editing
Yan Gong et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease
Hanseul Park et al.
NATURE NEUROSCIENCE (2019)
Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
Danny Wilbie et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
In utero gene editing for monogenic lung disease
Deepthi Alapati et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Near-infrared upconversion-activated CRISPR-Cas9 system: A remote-controlled gene editing platform
Yongchun Pan et al.
SCIENCE ADVANCES (2019)
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
Ji Liu et al.
ADVANCED MATERIALS (2019)
Triple-Targeting Delivery of CRISPR/Cas9 to Reduce the Risk of Cardiovascular Diseases
Lingmin Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss
Bence Gyorgy et al.
NATURE MEDICINE (2019)
CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model
Freja K. Ekman et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
Guojun Chen et al.
NATURE NANOTECHNOLOGY (2019)
Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance
Yue Zhang et al.
BIOMATERIALS (2019)
NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment
Qi Liu et al.
NANO LETTERS (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Engineered materials for in vivo delivery of genome-editing machinery
Sheng Tong et al.
NATURE REVIEWS MATERIALS (2019)
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
Alba Carreras et al.
BMC BIOLOGY (2019)
Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
Philippe E. Mangeot et al.
NATURE COMMUNICATIONS (2019)
Viral Vector-Based Delivery of CRISPR/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia B
Jian Gao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
Patrizia Tarugi et al.
JOURNAL OF BIOMEDICAL RESEARCH (2019)
Biomaterials as vectors for the delivery of CRISPR-Cas9
Joon Eoh et al.
BIOMATERIALS SCIENCE (2019)
Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework
Shahad K. Alsaiari et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Xue Gao et al.
NATURE (2018)
Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs
Daniel E. Ryan et al.
NUCLEIC ACIDS RESEARCH (2018)
Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
Ying-Li Luo et al.
ACS NANO (2018)
Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing
Wenhua Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
Ling Li et al.
BIOMATERIALS (2018)
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino et al.
DRUG DELIVERY (2018)
In vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency
Chun-Qing Song et al.
HUMAN GENE THERAPY (2018)
History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
Yoshizumi Ishino et al.
JOURNAL OF BACTERIOLOGY (2018)
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
Ema Robinson et al.
MOLECULAR THERAPY (2018)
Retained Plasticity and Substantial Recovery of Rod-Mediated Visual Acuity at the Visual Cortex in Blind Adult Mice with Retinal Dystrophy
Koji M. Nishiguchi et al.
MOLECULAR THERAPY (2018)
Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes
Francisco J. Blanco et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
Hong-Xia Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Engineering the Delivery System for CRISPR-Based Genome Editing
Zachary Glass et al.
TRENDS IN BIOTECHNOLOGY (2018)
Current Strategies for Brain Drug Delivery
Xiaowei Dong
THERANOSTICS (2018)
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn et al.
CELL REPORTS (2018)
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
Bumwhee Lee et al.
NATURE BIOMEDICAL ENGINEERING (2018)
In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia
Xiaolu Pan et al.
CIRCULATION RESEARCH (2018)
In Vivo Genome Editing as a Therapeutic Approach
Beatrice Xuan Ho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Optimized nanoparticle-mediated delivery of CRISPR-Cas9 system for B cell intervention
Min Li et al.
NANO RESEARCH (2018)
Directed evolution of CRISPR-Cas9 to increase its specificity
Jungjoon K. Lee et al.
NATURE COMMUNICATIONS (2018)
Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
Lukas Villiger et al.
NATURE MEDICINE (2018)
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Congfei Xu et al.
NATURE COMMUNICATIONS (2018)
Polycystic kidney disease
Carsten Bergmann et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
The Promise and Challenge of In Vivo Delivery for Genome Therapeutics
Ross C. Wilson et al.
ACS CHEMICAL BIOLOGY (2018)
Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice
Ling Li et al.
ACS NANO (2017)
Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
Kyoungmi Kim et al.
GENOME RESEARCH (2017)
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
Seung Min Kim et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Chang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Janice S. Chen et al.
NATURE (2017)
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
Hao Yin et al.
NATURE BIOTECHNOLOGY (2017)
Delivery technologies for genome editing
Hao Yin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease
Jonathan Wang et al.
BIOMATERIALS SCIENCE (2017)
Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core-Shell Nanocarrier
Peng Wang et al.
ADVANCED SCIENCE (2017)
In vivo genome editing improves motor function and extends survival in a mouse model of ALS
Thomas Gaj et al.
SCIENCE ADVANCES (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee et al.
NATURE BIOMEDICAL ENGINEERING (2017)
New Developments in CRISPR Technology: Improvements in Specificity and Efficiency
Fatemeh Safari et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2017)
In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice
Mona El Refaey et al.
CIRCULATION RESEARCH (2017)
Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles
Zeming Chen et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing
Alexandra C. Chadwick et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery
Hong-Xia Wang et al.
CHEMICAL REVIEWS (2017)
Calcium Signaling and Cardiac Arrhythmias
Andrew P. Landstrom et al.
CIRCULATION RESEARCH (2017)
Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors
Jie Zhu et al.
CELL RESEARCH (2017)
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
Rubul Mout et al.
BIOCONJUGATE CHEMISTRY (2017)
Heart targeted nanoliposomal/nanoparticles drug delivery: An updated review
Mostafa Cheraghi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing
Rubul Mout et al.
ACS NANO (2017)
A novel homozygous truncating GNAT1 mutation implicated in retinal degeneration
Matthew Carrigan et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems
Tetsushi Sakuma et al.
NATURE PROTOCOLS (2016)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
Chengzu Long et al.
SCIENCE (2016)
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar et al.
SCIENCE (2016)
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E. Nelson et al.
SCIENCE (2016)
CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report
Xiao Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
In Vivo Delivery Systems for Therapeutic Genome Editing
Luyao Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
Melissa L. Kelley et al.
JOURNAL OF BIOTECHNOLOGY (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang et al.
NATURE BIOTECHNOLOGY (2016)
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
Hao Yin et al.
NATURE BIOTECHNOLOGY (2016)
Applications of CRISPR technologies in research and beyond
Rodolphe Barrangou et al.
NATURE BIOTECHNOLOGY (2016)
Editing the epigenome: technologies for programmable transcription and epigenetic modulation
Pratiksha I. Thakore et al.
NATURE METHODS (2016)
Leaky RyR2 channels unleash a brainstem spreading depolarization mechanism of sudden cardiac death
Isamu Aiba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
Francis P. Pankowicz et al.
NATURE COMMUNICATIONS (2016)
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
Ji Young Yhee et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Alzheimer's Disease Neuroimaging Initiative: A decade of progress in Alzheimer's disease Foreword
William H. Thies
ALZHEIMERS & DEMENTIA (2015)
CRISPR genome engineering and viral gene delivery: A case of mutual attraction
Florian Schmidt et al.
BIOTECHNOLOGY JOURNAL (2015)
Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing
Nicolas Wyvekens et al.
HUMAN GENE THERAPY (2015)
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran et al.
NATURE (2015)
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Takeshi Maruyama et al.
NATURE BIOTECHNOLOGY (2015)
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
Van Trung Chu et al.
NATURE BIOTECHNOLOGY (2015)
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
Isaac B. Hilton et al.
NATURE BIOTECHNOLOGY (2015)
New treatment options for hearing loss
Ulrich Mueller et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
Areum Jo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
CRISPR genome engineering and viral gene delivery: A case of mutual attraction
Florian Schmidt et al.
BIOTECHNOLOGY JOURNAL (2015)
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Xiao-Hui Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Transmembrane channel-like (TMC) genes are required for auditory and vestibular mechanosensation
Yoshiyuki Kawashima et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
Qiurong Ding et al.
CIRCULATION RESEARCH (2014)
Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter
Jian-Hua Zhang et al.
JOURNAL OF BIOTECHNOLOGY (2014)
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
Walter Gubelin Harcha et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2014)
Fusion of catalytically inactive Cas9 to Fokl nuclease improves the specificity of genome modification
John P. Guilinger et al.
NATURE BIOTECHNOLOGY (2014)
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Hao Yin et al.
NATURE BIOTECHNOLOGY (2014)
Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity
Bhama Ramkhelawon et al.
NATURE MEDICINE (2014)
Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects
Bin Shen et al.
NATURE METHODS (2014)
Unravelling the structural and mechanistic basis of CRISPR-Cas systems
John van der Oost et al.
NATURE REVIEWS MICROBIOLOGY (2014)
CRISPR-Cas systems: beyond adaptive immunity
Edze R. Westra et al.
NATURE REVIEWS MICROBIOLOGY (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi et al.
CELL (2013)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
MicroRNA-34a regulates cardiac ageing and function
Reinier A. Boon et al.
NATURE (2013)
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
Prashant Mali et al.
NATURE BIOTECHNOLOGY (2013)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
Pablo Perez-Pinera et al.
NATURE METHODS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
TMC1 and TMC2 Are Components of the Mechanotransduction Channel in Hair Cells of the Mammalian Inner Ear
Bifeng Pan et al.
NEURON (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Genetics of Hearing and Deafness
Simon Angeli et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2012)
Evidence-Based Path to Newborn Screening for Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2012)
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus
Eugene L. Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice
Mi Hee Kwack et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Holly B. Kordasiewicz et al.
NEURON (2012)
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Giedrius Gasiunas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene/Allele-Specific Silencing of Mutant Huntingtin
Jeffrey B. Carroll et al.
MOLECULAR THERAPY (2011)
A nonsense mutation in Gnat1, encoding the alpha subunit of rod transducin, in spontaneous mouse models of retinal dysfunction
Makoto Miyamoto et al.
EXPERIMENTAL EYE RESEARCH (2010)
Visual Responses in Mice Lacking Critical Components of All Known Retinal Phototransduction Cascades
Annette E. Allen et al.
PLOS ONE (2010)
Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia
Meiso Hayashi et al.
CIRCULATION (2009)
Targeted delivery of nanoparticles for the treatment of lung diseases
Shirzad Azarmi et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings
Mitch McVey et al.
TRENDS IN GENETICS (2008)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease
M Díaz-Hernández et al.
JOURNAL OF NEUROSCIENCE (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Polo-like kinases and oncogenesis
F Eckerdt et al.
ONCOGENE (2005)
Viral and non-viral vectors in gene therapy: Technology development and clinical trials
K Lundstrom et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Angptl3 regulates lipid metabolism in mice
R Koishi et al.
NATURE GENETICS (2002)
Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function
K Kurima et al.
NATURE GENETICS (2002)
Identification of genes that are associated with DNA repeats in prokaryotes
R Jansen et al.
MOLECULAR MICROBIOLOGY (2002)
Medical progress - The hemophilias - From royal genes to gene therapy
PM Mannucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Medical progress: Amyotrophic lateral sclerosis.
LP Rowland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Altered stability of pulmonary surfactant in SP-C-deficient mice
SW Glasser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Biological significance of a family of regularly spaced repeats in the genomes of Archaea, bacteria and mitochondria
FJM Mojica et al.
MOLECULAR MICROBIOLOGY (2000)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)
Share Paper
